Skip to navigation Skip to sub-navigation Skip to content

People

Caley Smith

Caley Smith

Ph.D. Candidate, Molecular Pathogenesis and Therapeutics

caleysmith@mail.missouri.edu

News about Caley Smith

AAV9-DOK7 gene therapy reduces disease severity in Smn2B/- SMA model mice. Kaifer KA, Villalón E, Smith CE, Simon ME, Marquez J, Hopkins AE, Morcos TI, Lorson CL. Biochemical and Biophysical Research Communications; 530(1):107-114.

Featured in this article: Caley Smith, Christian Lorson.

Go to article...

Development of a novel severe mouse model of spinal muscular atrophy with respiratory distress type 1: FVB-nmd. Shababi M, Smith CE, Kacher M, Alrawi Z, Villalón E, Davis D, Bryda EC, Lorson CL. Biochemical and Biophysical Research Communications; 520(2):341-346.

Featured in this article: Caley Smith, Mona Kacher, Christian Lorson.

Go to article...

AAV9-Stathmin1 gene delivery improves disease phenotype in an intermediate mouse model of spinal muscular atrophy. Villalón E, Kline RA, Smith CE, Lorson ZC, Osman EY, O'day S, Murray LM, Lorson CL. Human Molecular Genetics; 28(22):3742-3754.

Featured in this article: Caley Smith, Christian Lorson.

Go to article...

AAV9-mediated delivery of miR-23a reduces disease severity in Smn2B/-SMA model mice. Kaifer KA, Villalón E, O'Brien BS, Sison SL, Smith CE, Simon ME, Marquez J, O'Day S, Hopkins AE, Neff R, Rindt H, Ebert AD, Lorson CL. Human Molecular Genetics; 28(19):3199-3210.

Featured in this article: Caley Smith, Christian Lorson.

Go to article...